Cognitive impairment and structural brain damage in benign multiple sclerosis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objective: Although in benign multiple sclerosis (BMS) locomotor disability is absent or only minimal, subclinical cognitive impairment seems to occur in many cases. Diffusion tensor (DT) MRI enables us to quantify the extent of “actual” tissue damage, which goes undetected when using conventional MRI. Against this background, we investigated the extent of structural brain damage underlying cognitive dysfunction in BMS, with the ultimate aim to move a first step toward a more reliable definition of this disease phenotype. Methods: Conventional and DT MRI scans of the brain were acquired from 62 BMS patients. Thirty-six secondary progressive multiple sclerosis (SPMS) patients and 19 healthy subjects served as controls. In BMS patients, neuropsychological tests exploring memory, attention, and frontal lobe functions were administered. Normalized brain volume (NBV), mean diffusivity (MD), and fractional anisotropy (FA) of the normal-appearing white matter (NAWM) and MD of the gray matter (GM) were computed. Results: Twelve BMS patients (19%) fulfilled predefined criteria for cognitive impairment. BMS patients had abnormal MD and FA values from both NAWM and GM. Whereas BMS patients without cognitive impairment had lower T2 LV (p = 0.03), higher NBV (p = 0.006), and lower average GM MD (p = 0.03) than SPMS patients, BMS patients with cognitive impairment did not significantly differ from SPMS patients for any MRI-derived metric. Conclusions: In benign multiple sclerosis (BMS), cognitive dysfunction is associated with severe structural brain damage, which resembles that of patients with a much more disabling disease course. A reliable definition of BMS should, therefore, include the preservation of cognitive functioning as an additional requisite. GLOSSARY: BMS = benign multiple sclerosis; DT = diffusion tensor; EDSS = Expanded Disability Status Scale; FA = fractional anisotropy; FDR = false discovery rate; FOV = field of view; GM = gray matter; LV = lesion volume; MD = mean diffusivity; MP-RAGE = magnetization-prepared rapid-acquisition gradient echo; MS = multiple sclerosis; NAWM = normal-appearing white matter; NBV = normalized volume; PASAT = Paced Auditory Serial Attention Test–3" Version; PGSE = pulsed-gradient echo-planar; ROCF = Rey–Osterrieth Complex Figure; SPMS = secondary progressive multiple sclerosis; TE = echo time; TR = repetition time; WM = white matter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion
Gronwall, D. M. A. (1977) · Perceptual and Motor Skills · doi:10.2466/pms.1977.44.2.367 · Cited by 2,395
Administration and interpretation of the Trail Making Test
Bowie, C. R., & Harvey, P. D. (2006) · Nature Protocols · doi:10.1038/nprot.2006.390 · Cited by 1,418
Cited by
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues
Benedict, R. H. B., Amato, M. P., DeLuca, J., & Geurts, J. J. G. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30277-5 · Cited by 764
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
Rocca, M. A., Amato, M. P., De Stefano, N., Enzinger, C., Geurts, J. J., Penner, I.-K., Rovira, A., Sumowski, J. F., Valsasina, P., & Filippi, M. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70250-9 · Cited by 557
Self-citationNew perspectives in the natural history of multiple sclerosis
Tremlett, H., Zhao, Y., Rieckmann, P., & Hutchinson, M. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e3973f · Cited by 261
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications
Sbardella, E., Tona, F., Petsas, N., & Pantano, P. (2013) · Multiple Sclerosis International · doi:10.1155/2013/671730 · Cited by 172
“Adults with benign MS have also exhibited changes in DTI [19, 21, 74], consisting in particular of an increase in MD [75], which thus suggests that demyelination prevails over axonal damage when the disease is clinically less severe.”
BackgroundSerum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis
Niiranen, M., Kontkanen, A., Jääskeläinen, O., Tertsunen, H.-M., Selander, T., Hartikainen, P., Huber, N., Solje, E., Haapasalo, A., Kokkola, T., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103280 · Cited by 25
Metadata
- Authors
- Rovaris, M., Riccitelli, G., Judica, E., Possa, F., Caputo, D., Ghezzi, A., Bertolotto, A., Capra, R., Falautano, M., Mattioli, F., Martinelli, V., Comi, G., & Filippi, M.
- Venue
- Neurology
- Published
- 2008-11-04
- Volume
- 71
- Issue
- 19
- Pages
- 1521-1526
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2107548206
- Cited by
- 91
- References
- 3
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cognitive impairment and structural brain damage in benign multiple sclerosis. https://app.cochat.ai/papers/10.1212/01.wnl.0000319694.14251.95
- The paper
- Rovaris, M., Riccitelli, G., Judica, E., Possa, F., Caputo, D., Ghezzi, A., Bertolotto, A., Capra, R., Falautano, M., Mattioli, F., Martinelli, V., Comi, G., & Filippi, M. (2008). Cognitive impairment and structural brain damage in benign multiple sclerosis. Neurology. https://doi.org/10.1212/01.wnl.0000319694.14251.95
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.